Significant detrimental impact of pre-transplant mogamulizumab on the post-transplant outcome with a short interval between the last mogamulizumab and transplantation

S.F. and M.Y. designed the study. S.F., M.T., K.K., N.N., T.S., J.M., H.I., A.I., T.E., J.I., Y.H., K.I., Y.M., S.O., Y.M., S.Y., K.T., Y.K., M.O., T.F., Y.A., and M.Y. collected the data. S.F. performed the statistical analysis. S.F., M.T., K.K., N.N., and M.Y. wrote the manuscript. All authors agreed to submit the final version of the manuscript.

留言 (0)

沒有登入
gif